Safety, Tolerability, Pharmacokinetics and Efficacy of 180 mg Subcutaneous Risperidone From 6 mg Oral Risperidone
Clinical trial NCT03978832 · COMPLETED
Trial details
- NCT number
- NCT03978832
- Sponsor
- Indivior Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-28
- Primary completion
- 2020-05-12
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.